Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
68,936,606
-
Share change
-
+275,046
-
Total reported value
-
$1,642,725,804
-
Put/Call ratio
-
35%
-
Price per share
-
$23.83
-
Number of holders
-
201
-
Value change
-
+$6,756,500
-
Number of buys
-
101
-
Number of sells
-
87
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2016
As of 30 Jun 2016,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,936,606 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, OAK RIDGE INVESTMENTS LLC, Bank of New York Mellon Corp, Van Berkom & Associates Inc., BlackRock Fund Advisors, TimesSquare Capital Management, LLC, ABERDEEN ASSET MANAGEMENT PLC/UK, and BlackRock Institutional Trust Company, N.A..
This page lists
201
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.